-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FP-045 in Fanconi Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FP-045 in Fanconi Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FP-045 in Fanconi Anemia Drug Details: FP-045 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FP-045 in Cardiometabolic Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FP-045 in Cardiometabolic Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FP-045 in Cardiometabolic Disease Drug Details: FP-045 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapagliflozin Propanediol in Diastolic Heart Failure (HFpEF)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dapagliflozin Propanediol in Diastolic Heart Failure (HFpEF) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dapagliflozin Propanediol in Diastolic Heart Failure (HFpEF) Drug...
-
Analyst Opinions
NewElectricals Market Size, Trends and Analysis by Regional and Category Performance, Brands and Forecast to 2028
Electricals Market Report Overview The electricals market size was valued at $1.44 trillion in 2023 and the market will grow at a CAGR of more than 3% during 2023-2028. This heightened growth trajectory stems from continued technological advances and consumers leaning toward smart and eco-friendly devices. However, the rise of the secondhand market threatens the growth of the electricals market, taking spending away from traditional retail. Electricals Market Outlook 2023-2028 ($ Trillion) Buy the Full Report for More Insights on...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Product Insights
Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview The transcatheter heart valve is an artificial heart valve made up of natural tissue surrounded by a flexible mesh frame known as stent. All the components are placed in a long narrow tube known as a catheter which is then inserted into a large blood vessel in the groin area or through a small incision in chest. The transcatheter mitral valve implantation (TMVI) pipeline market research report provides a comprehensive understanding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golocdacimab in Myocardial Infarction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golocdacimab in Myocardial Infarction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golocdacimab in Myocardial Infarction Drug Details: Golocdacimab (MEDI-6570) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golocdacimab in Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golocdacimab in Coronary Artery Disease (CAD) (Ischemic Heart Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golocdacimab in Coronary Artery Disease (CAD) (Ischemic...
-
Sector Analysis
Uzbekistan Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Uzbekistan Defense Market Report Overview The Uzbekistan defense budget was worth $2.67 billion in 2023. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 2% between 2024 and 2028. Factors such as the likelihood of armed provocations and growing religious extremism in neighboring countries are expected to drive the market growth. In addition, the plan of the government to make structural changes to its armed forces, along with modernization and the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dapagliflozin Propanediol in Diastolic Heart Failure (HFpEF)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Dapagliflozin Propanediol in Diastolic Heart Failure (HFpEF) Drug Details: Dapagliflozin (Forxiga, Edistride, Gledepa, Duforzig, Kedgeo,...